Megan Sarah Jean Arnold
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Megan Sarah Jean Arnold has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
Anthony Carlson Greene
School of Natural Sciences Griffith University Nathan Campus Queensland AUSTRALIA
5 shared publications- Ian Edwin Cock
School of Environment and Science, Griffith University, Nathan Campus, Qld 4111, Australia
5 shared publications Mitchell Henry Wright
Division of Environmental and Biomolecular Systems Institute of Environmental Health Oregon Health & Science University Portland Oregon USA
5 shared publicationsCameron Jay Lee
School of Natural Sciences Griffith University Nathan Campus Queensland AUSTRALIA
3 shared publications- Katherine T. Andrews
Institute for Biomedicine and Glycomics Griffith University Southport Queensland Australia
3 shared publications - Gillian M. Fisher
Eskitis Institute for Drug Discovery, Griffith University, Nathan, Queensland 4111, Australia
2 shared publications
Latest Publications
- Open Access
- 15 July 2017
- Published by Manuscript Technomedia LLP in Pharmacognosy Journal
- Vol. 9 (5) , 626-637
GC-MS analysis of Tasmannia lanceolata Extracts which Inhibit the Growth of the Pathogenic Bacterium Clostridium perfringens
Introduction: Clostridium perfringens is the etiological agent of clostridial myonecrosis and enteritis necroticans. Infections result in exotoxin production, tissue necrosis and unless promptly treated, often result in death. Methods: Tasmannia lanceolata extracts were investigated for C. perfringens growth inhibitory activity by disc diffusion analysis and MIC determination. Toxicity was evaluated by Artemia nauplii bioassay and the most potent extracts were phytochemically evaluated by GC-MS headspace analysis. Results: All T. lanceolata berry and leaf extracts displayed potent C. perfringens growth inhibition. The berry extracts were more potent growth inhibitors than the corresponding leaf extracts, although the leaf extracts were also potent growth inhibitors. The berry aqueous, methanolic and ethyl acetate extracts were particularly potent growth inhibitors, with MIC values of 654, 65 and 329 µg/mL respectively. T. lanceolata leaf also displayed good efficacy, with an MIC of 839, 1255 and 625 µg/mL for the aqueous, methanolic and ethyl acetate extracts respectively. All extracts were nontoxic in the Artemia franciscana bioassay, with LC 50 values substantially > 1000 µg/mL. Non-biased GC-MS analysis of the aqueous, methanolic and ethyl acetate berry extracts revealed the presence of high relative levels of a diversity of terpenoids. Conclusions: The lack of toxicity of the T. lanceolata extracts and their potent growth inhibitory bioactivity against C. perfringens indicates their potential as medicinal agents in the treatment and prevention of clostridial myonecrosis and enteritis necroticans. GC-MS metabolomic profiling studies indicate that these extracts contained a diversity of terpenoids, with monoterpenoids being particularly abundant.
- 15 July 2017
- Published by Manuscript Technomedia LLP in Pharmacognosy Journal
- Vol. 9 (5) , 626-637
Open AccessGC-MS analysis of Tasmannia lanceolata Extracts which Inhibit the Growth of the Pathogenic Bacterium Clostridium perfringens
Introduction: Clostridium perfringens is the etiological agent of clostridial myonecrosis and enteritis necroticans. Infections result in exotoxin production, tissue necrosis and unless promptly treated, often result in death. Methods: Tasmannia lanceolata extracts were investigated for C. perfringens growth inhibitory activity by disc diffusion analysis and MIC determination. Toxicity was evaluated by Artemia nauplii bioassay and the most potent extracts were phytochemically evaluated by GC-MS headspace analysis. Results: All T. lanceolata berry and leaf extracts displayed potent C. perfringens growth inhibition. The berry extracts were more potent growth inhibitors than the corresponding leaf extracts, although the leaf extracts were also potent growth inhibitors. The berry aqueous, methanolic and ethyl acetate extracts were particularly potent growth inhibitors, with MIC values of 654, 65 and 329 µg/mL respectively. T. lanceolata leaf also displayed good efficacy, with an MIC of 839, 1255 and 625 µg/mL for the aqueous, methanolic and ethyl acetate extracts respectively. All extracts were nontoxic in the Artemia franciscana bioassay, with LC 50 values substantially > 1000 µg/mL. Non-biased GC-MS analysis of the aqueous, methanolic and ethyl acetate berry extracts revealed the presence of high relative levels of a diversity of terpenoids. Conclusions: The lack of toxicity of the T. lanceolata extracts and their potent growth inhibitory bioactivity against C. perfringens indicates their potential as medicinal agents in the treatment and prevention of clostridial myonecrosis and enteritis necroticans. GC-MS metabolomic profiling studies indicate that these extracts contained a diversity of terpenoids, with monoterpenoids being particularly abundant.
- Open Access
- 1 April 2017
- Published by Elsevier in International Journal for Parasitology: Drugs and Drug Resistance
- Vol. 7 (1) , 61-70
Investigating the antiplasmodial activity of primary sulfonamide compounds identified in open source malaria data
- 1 April 2017
- Published by Elsevier in International Journal for Parasitology: Drugs and Drug Resistance
- Vol. 7 (1) , 61-70
Open AccessInvestigating the antiplasmodial activity of primary sulfonamide compounds identified in open source malaria data
- Open Access
- 1 April 2017
- Published by Elsevier in International Journal for Parasitology: Drugs and Drug Resistance
- Vol. 7 (1) , 42-50
Effect of clinically approved HDAC inhibitors on Plasmodium, Leishmania and Schistosoma parasite growth
- 1 April 2017
- Published by Elsevier in International Journal for Parasitology: Drugs and Drug Resistance
- Vol. 7 (1) , 42-50
Open AccessEffect of clinically approved HDAC inhibitors on Plasmodium, Leishmania and Schistosoma parasite growth
- 1 July 2016
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 60 (7) , 4361-4363
Adaptation of the [ 3 H]Hypoxanthine Uptake Assay for In Vitro -Cultured Plasmodium knowlesi Malaria Parasites
The zoonotic malaria parasite Plasmodium knowlesi has recently been established in continuous in vitro culture. Here, the Plasmodium falciparum [ 3 H]hypoxanthine uptake assay was adapted for P. knowlesi and used to determine the sensitivity of this parasite to chloroquine, cycloguanil, and clindamycin. The data demonstrate that P. knowlesi is sensitive to all drugs, with 50% inhibitory concentrations (IC 50 s) consistent with those obtained with P. falciparum . This assay provides a platform to use P. knowlesi in vitro for drug discovery.
- 1 July 2016
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 60 (7) , 4361-4363
Adaptation of the [ 3 H]Hypoxanthine Uptake Assay for In Vitro -Cultured Plasmodium knowlesi Malaria Parasites
The zoonotic malaria parasite Plasmodium knowlesi has recently been established in continuous in vitro culture. Here, the Plasmodium falciparum [ 3 H]hypoxanthine uptake assay was adapted for P. knowlesi and used to determine the sensitivity of this parasite to chloroquine, cycloguanil, and clindamycin. The data demonstrate that P. knowlesi is sensitive to all drugs, with 50% inhibitory concentrations (IC 50 s) consistent with those obtained with P. falciparum . This assay provides a platform to use P. knowlesi in vitro for drug discovery.
- Open Access
- 1 June 2016
- Published by Manuscript Technomedia LLP in Pharmacognosy Communications
- Vol. 6 (3) , 164-173
Inhibition of Streptococcus pyogenes growth by native Australian plants: New approaches towards the management of impetigo, pharyngitis and rheumatic heart disease
Introduction: Streptococcus pyogenes can cause a variety of diseases including streptococcal pharyngitis, impetigo and rheumatic heart disease, dependant on which tissue it infects. Many Australian plants have documented therapeutic properties as general antiseptics, but are yet to be tested for the ability to inhibit S. pyogenes growth. Methods: Solvent extracts were prepared using Australian plants with documented ethnobotanical usage to treat bacterial infections, or published antibacterial activity. The extracts were investigated by disc diffusion assay for the ability to inhibit the growth of a clinical strain of S. pyogenes. Their MIC values were determined to quantify and compare their efficacies. Toxicity was determined using the Artemia franciscana nauplii bioassay. Results: S. pyogenes growth was inhibited by 24 of the 34 extracts tested. The Eucalyptus spp. extracts were particularly potent. MIC values of 341 and 88 µg/ mL were determined for the aqueous and methanolic E. baileyana extracts respectively. Similarly, MIC values of 134 and 53 µg/mL were determined for the aqueous and methanolic E. major extracts respectively. The methanolic wattle seed extract, aqueous and methanolic lemon aspen extracts, aqueous native thyme extract, methanolic river mint extract and the methanolic native basil extract were similarly potent growth inhibitors, with MIC values ≤1000 µg/mL. Several other extracts (methanolic native tamarind, bush tomato, desert lime, native thyme, native sage and the T. stipitata leaf extracts, as well as the aqueous river mint, native basil, T. stipitata leaf extracts) displayed moderate growth inhibitory activity (MIC=1000-5000 µg/mL). All other extracts were either low potency S. pyogenes growth inhibitors or were devoid of inhibitory activity. The E. baileyana and E. major methanolic extracts, as well as the E. baileyana aqueous extract induced significant mortality in the Artemia fransiscana bioassay, with LC 50 values substantially 1000 µg/mL. Conclusion: The potent growth inhibitory bioactivity of the Eucalyptus spp., lemon aspen, wattle seed, native basil and river mint extracts against S. pyogenes demonstrates their potential for the treatment and prevention of S. pyogenes induced disease. However, the toxicity of the Eucalyptus spp. extracts may limit their use to topical treatments for pharyngitis and impetigo. As the lemon aspen, wattle seed, native basil and river mint extracts were nontoxic, they may also have wider uses in treating systemic illnesses such as rheumatic fever, rheumatic heart disease and cellulitis.
- 1 June 2016
- Published by Manuscript Technomedia LLP in Pharmacognosy Communications
- Vol. 6 (3) , 164-173
Open AccessInhibition of Streptococcus pyogenes growth by native Australian plants: New approaches towards the management of impetigo, pharyngitis and rheumatic heart disease
Introduction: Streptococcus pyogenes can cause a variety of diseases including streptococcal pharyngitis, impetigo and rheumatic heart disease, dependant on which tissue it infects. Many Australian plants have documented therapeutic properties as general antiseptics, but are yet to be tested for the ability to inhibit S. pyogenes growth. Methods: Solvent extracts were prepared using Australian plants with documented ethnobotanical usage to treat bacterial infections, or published antibacterial activity. The extracts were investigated by disc diffusion assay for the ability to inhibit the growth of a clinical strain of S. pyogenes. Their MIC values were determined to quantify and compare their efficacies. Toxicity was determined using the Artemia franciscana nauplii bioassay. Results: S. pyogenes growth was inhibited by 24 of the 34 extracts tested. The Eucalyptus spp. extracts were particularly potent. MIC values of 341 and 88 µg/ mL were determined for the aqueous and methanolic E. baileyana extracts respectively. Similarly, MIC values of 134 and 53 µg/mL were determined for the aqueous and methanolic E. major extracts respectively. The methanolic wattle seed extract, aqueous and methanolic lemon aspen extracts, aqueous native thyme extract, methanolic river mint extract and the methanolic native basil extract were similarly potent growth inhibitors, with MIC values ≤1000 µg/mL. Several other extracts (methanolic native tamarind, bush tomato, desert lime, native thyme, native sage and the T. stipitata leaf extracts, as well as the aqueous river mint, native basil, T. stipitata leaf extracts) displayed moderate growth inhibitory activity (MIC=1000-5000 µg/mL). All other extracts were either low potency S. pyogenes growth inhibitors or were devoid of inhibitory activity. The E. baileyana and E. major methanolic extracts, as well as the E. baileyana aqueous extract induced significant mortality in the Artemia fransiscana bioassay, with LC 50 values substantially 1000 µg/mL. Conclusion: The potent growth inhibitory bioactivity of the Eucalyptus spp., lemon aspen, wattle seed, native basil and river mint extracts against S. pyogenes demonstrates their potential for the treatment and prevention of S. pyogenes induced disease. However, the toxicity of the Eucalyptus spp. extracts may limit their use to topical treatments for pharyngitis and impetigo. As the lemon aspen, wattle seed, native basil and river mint extracts were nontoxic, they may also have wider uses in treating systemic illnesses such as rheumatic fever, rheumatic heart disease and cellulitis.
- Open Access
- 1 June 2016
- Published by Manuscript Technomedia LLP in Pharmacognosy Communications
- Vol. 6 (3) , 152-163
Bioactive constituents of Terminalia ferdinandiana Exell: A pharmacognistic approach towards the prevention and treatment of yersiniosis
Introduction: Yersinia enterocolitica is a facultatively anaerobic gram negative bacterium which contaminates meat products causing the acute gastrointestinal disease yersiniosis. Terminalia ferdinandiana (Kakadu plum, gubinge) is an Australian fruit with an extremely high antioxidant capacity. It was used therapeutically by the first Australians and has documented antiseptic properties against an extensive panel of bacteria. Despite this, it has not been tested for the ability to inhibit the growth of Y. enterocolitica. Methods: T. ferdinandiana fruit and leaf extracts were extracted by maceration and the extracts were investigated by disc diffusion assay for growth inhibitory activity against a clinical strain of Y. enterocolitica. The MIC values of the extracts were determined to quantify and compare their efficacies. Toxicity was determined using the Artemia franciscana nauplii bioassay. The most potent extracts were investigated using non-targeted GC-MS analysis (with screening against a compound database) for the identification and characterisation of individual components in the crude plant extracts. Results: Solvent extractions of T. ferdinandiana leaf and fruit displayed good growth inhibitory activity in the disc diffusion assay against Y. enterocolitica. The methanolic T. ferdinandiana leaf and fruit extracts, as well as the fruit ethyl acetate extract, were particularly potent growth inhibitors, with MIC values of 372, 123 and 285 µg/mL respectively. The aqueous and ethyl acetate leaf extracts also displayed good growth inhibitory activity against Y. enterocolitica, albeit with higher MIC values (588 and 1100 µg/mL respectively). All other extracts were either low efficacy, or completely devoid of growth inhibitory activity. All T. ferdinandiana leaf and fruit extracts were either nontoxic (LC 50 values <1000 µg/mL) or of low toxicity in the Artemia franciscana bioassay. Non-biased GC-MS phytochemical analysis of the methanolic extracts putatively identified and highlighted several compounds that may contribute to the ability of these extracts to inhibit the growth of Y. enterocolitica. Conclusion: The lack of toxicity and the potent growth inhibitory bioactivity of the T. ferdinandiana fruit and leaf methanolic extracts against Y. enterocolitica indicates their potential as medicinal agents in the treatment and prevention of yersiniosis.
- 1 June 2016
- Published by Manuscript Technomedia LLP in Pharmacognosy Communications
- Vol. 6 (3) , 152-163
Open AccessBioactive constituents of Terminalia ferdinandiana Exell: A pharmacognistic approach towards the prevention and treatment of yersiniosis
Introduction: Yersinia enterocolitica is a facultatively anaerobic gram negative bacterium which contaminates meat products causing the acute gastrointestinal disease yersiniosis. Terminalia ferdinandiana (Kakadu plum, gubinge) is an Australian fruit with an extremely high antioxidant capacity. It was used therapeutically by the first Australians and has documented antiseptic properties against an extensive panel of bacteria. Despite this, it has not been tested for the ability to inhibit the growth of Y. enterocolitica. Methods: T. ferdinandiana fruit and leaf extracts were extracted by maceration and the extracts were investigated by disc diffusion assay for growth inhibitory activity against a clinical strain of Y. enterocolitica. The MIC values of the extracts were determined to quantify and compare their efficacies. Toxicity was determined using the Artemia franciscana nauplii bioassay. The most potent extracts were investigated using non-targeted GC-MS analysis (with screening against a compound database) for the identification and characterisation of individual components in the crude plant extracts. Results: Solvent extractions of T. ferdinandiana leaf and fruit displayed good growth inhibitory activity in the disc diffusion assay against Y. enterocolitica. The methanolic T. ferdinandiana leaf and fruit extracts, as well as the fruit ethyl acetate extract, were particularly potent growth inhibitors, with MIC values of 372, 123 and 285 µg/mL respectively. The aqueous and ethyl acetate leaf extracts also displayed good growth inhibitory activity against Y. enterocolitica, albeit with higher MIC values (588 and 1100 µg/mL respectively). All other extracts were either low efficacy, or completely devoid of growth inhibitory activity. All T. ferdinandiana leaf and fruit extracts were either nontoxic (LC 50 values <1000 µg/mL) or of low toxicity in the Artemia franciscana bioassay. Non-biased GC-MS phytochemical analysis of the methanolic extracts putatively identified and highlighted several compounds that may contribute to the ability of these extracts to inhibit the growth of Y. enterocolitica. Conclusion: The lack of toxicity and the potent growth inhibitory bioactivity of the T. ferdinandiana fruit and leaf methanolic extracts against Y. enterocolitica indicates their potential as medicinal agents in the treatment and prevention of yersiniosis.
- Open Access
- 1 April 2016
- Published by Manuscript Technomedia LLP in Pharmacognosy Communications
- Vol. 6 (2) , 85-92
Qualitative Phytochemical Analysis and Antibacterial Activity Evaluation of Indian Terminalia spp. Against the Pharyngitis Causing Pathogen Streptococcus pyogenes.
Introduction: Streptococcus pyogenes is a gram-positive, pathogenic bacterium which causes a variety of diseases including streptococcal pharyngitis, impetigo and rheumatic heart disease, depending on which tissue it infects. Many Terminalia spp. have documented therapeutic properties as general antiseptics, inhibiting the growth of a wide variety of bacterial species. Methods: Solvent extracts were prepared using Indian Terminalia spp. with documented ethnobotanical usage to treat bacterial infections, or published antibacterial activity. The extracts were investigated by disc diffusion assay for the ability to inhibit the growth of a clinical strain of S. pyogenes. Their MIC values were determined to quantify and compare their efficacies. Toxicity was determined using the Artemia franciscana nauplii bioassay. Results: T. arjuna, T. catappa and T. chebula methanolic and ethyl acetate extracts displayed potent antibacterial activity in the disc diffusion assay against S. pyogenes. The T. catappa and T. chebula ethyl acetate extracts were particularly potent, with MIC values of 225 and 205 µg/mL respectively. All methanolic extracts were also potent growth inhibitors with MIC values of 268 µg/mL (T. arjuna methanolic extract), 425 µg/mL (T. catappa methanolic extract) and 300 µg/mL (T. chebula methanolic extract). The T. catappa hexane extract was also a potent S. pyogenes growth inhibitor (MIC 768 µg/mL). All other extracts were either ineffective or were of only low efficacy. Furthermore, all of the Indian Terminalia spp. extracts were nontoxic in the Artemia fransiscana bioassay, with LC 50 values >1000 µg/mL. Conclusion: The potent growth inhibitory bioactivity of the methanolic and ethyl acetate T. arjuna, T. catappa and T. chebula extracts against S. pyogenes demonstrates their potential for the treatment and prevention of pharyngitis, impetigo and rheumatic heart disease. All extracts were nontoxic indicating their safety for therapeutic use.
- 1 April 2016
- Published by Manuscript Technomedia LLP in Pharmacognosy Communications
- Vol. 6 (2) , 85-92
Open AccessQualitative Phytochemical Analysis and Antibacterial Activity Evaluation of Indian Terminalia spp. Against the Pharyngitis Causing Pathogen Streptococcus pyogenes.
Introduction: Streptococcus pyogenes is a gram-positive, pathogenic bacterium which causes a variety of diseases including streptococcal pharyngitis, impetigo and rheumatic heart disease, depending on which tissue it infects. Many Terminalia spp. have documented therapeutic properties as general antiseptics, inhibiting the growth of a wide variety of bacterial species. Methods: Solvent extracts were prepared using Indian Terminalia spp. with documented ethnobotanical usage to treat bacterial infections, or published antibacterial activity. The extracts were investigated by disc diffusion assay for the ability to inhibit the growth of a clinical strain of S. pyogenes. Their MIC values were determined to quantify and compare their efficacies. Toxicity was determined using the Artemia franciscana nauplii bioassay. Results: T. arjuna, T. catappa and T. chebula methanolic and ethyl acetate extracts displayed potent antibacterial activity in the disc diffusion assay against S. pyogenes. The T. catappa and T. chebula ethyl acetate extracts were particularly potent, with MIC values of 225 and 205 µg/mL respectively. All methanolic extracts were also potent growth inhibitors with MIC values of 268 µg/mL (T. arjuna methanolic extract), 425 µg/mL (T. catappa methanolic extract) and 300 µg/mL (T. chebula methanolic extract). The T. catappa hexane extract was also a potent S. pyogenes growth inhibitor (MIC 768 µg/mL). All other extracts were either ineffective or were of only low efficacy. Furthermore, all of the Indian Terminalia spp. extracts were nontoxic in the Artemia fransiscana bioassay, with LC 50 values >1000 µg/mL. Conclusion: The potent growth inhibitory bioactivity of the methanolic and ethyl acetate T. arjuna, T. catappa and T. chebula extracts against S. pyogenes demonstrates their potential for the treatment and prevention of pharyngitis, impetigo and rheumatic heart disease. All extracts were nontoxic indicating their safety for therapeutic use.
- 13 January 2016
- Published by Oxford University Press (OUP) in International Journal of Food Science and Technology
- Vol. 51 (3) , 801-813
The prevention of fish spoilage by high antioxidant Australian culinary plants: Shewanella putrefaciens growth inhibition
Summary: Shewanella putrefaciens is a marine bacterium and a major microbial cause of spoilage in low temperature stored seafood. A survey of fruits and culinary herbs was undertaken on Australian plants with high antioxidant capacities. Twenty‐eight extracts from thirteen plant species were investigated for the ability to inhibit S. putrefaciens growth. Of these, eight extracts (28.6%) substantially inhibited S. putrefaciens growth. The muntries (Kunzea pomifera), lemon aspen (Acronychia acidula) and desert lime (Citrus glauca) extracts were efficient anti‐S. putrefaciens agents, with MIC values ≤3000 μg mL−1. Of these, the muntries methanolic extract was the most potent growth inhibitor (MIC = 2240 μg mL−1). The aqueous desert lime extract was also an effective growth inhibitor (MIC of 3857 μg mL−1), whilst the methanolic bush tomato (Solanum aviculare), aqueous muntries and Davidson's plum (Davidsonia pruriens) extracts displayed moderate S. putrefaciens growth inhibition. All extracts were nontoxic in the Artemia fransiscana bioassay, with LC50 values (>1000 μg mL−1). Nontargeted HPLC‐QTOF mass spectroscopy (with screening against three compound databases) putatively identified twenty compounds that were present in both inhibitory muntries extracts. The low toxicity of these extracts and their inhibitory bioactivity against S. putrefaciens indicates their potential as natural fish and seafood preservatives.
- 13 January 2016
- Published by Oxford University Press (OUP) in International Journal of Food Science and Technology
- Vol. 51 (3) , 801-813
The prevention of fish spoilage by high antioxidant Australian culinary plants: Shewanella putrefaciens growth inhibition
Summary: Shewanella putrefaciens is a marine bacterium and a major microbial cause of spoilage in low temperature stored seafood. A survey of fruits and culinary herbs was undertaken on Australian plants with high antioxidant capacities. Twenty‐eight extracts from thirteen plant species were investigated for the ability to inhibit S. putrefaciens growth. Of these, eight extracts (28.6%) substantially inhibited S. putrefaciens growth. The muntries (Kunzea pomifera), lemon aspen (Acronychia acidula) and desert lime (Citrus glauca) extracts were efficient anti‐S. putrefaciens agents, with MIC values ≤3000 μg mL−1. Of these, the muntries methanolic extract was the most potent growth inhibitor (MIC = 2240 μg mL−1). The aqueous desert lime extract was also an effective growth inhibitor (MIC of 3857 μg mL−1), whilst the methanolic bush tomato (Solanum aviculare), aqueous muntries and Davidson's plum (Davidsonia pruriens) extracts displayed moderate S. putrefaciens growth inhibition. All extracts were nontoxic in the Artemia fransiscana bioassay, with LC50 values (>1000 μg mL−1). Nontargeted HPLC‐QTOF mass spectroscopy (with screening against three compound databases) putatively identified twenty compounds that were present in both inhibitory muntries extracts. The low toxicity of these extracts and their inhibitory bioactivity against S. putrefaciens indicates their potential as natural fish and seafood preservatives.